Candela Medical, Inc.

Candela Medical, Inc., commonly known as Candela, is a global medical aesthetic device company headquartered in Marlborough, Massachusetts, USA. Founded in 1970, the company is privately held and was acquired by an affiliate of funds advised by Apax Partners in July 2017, operating as a subsidiary of Dion Topco L.P. Candela employs approximately 600-900 individuals, with estimated annual revenues ranging from $187 million to $600 million across various reporting years. The company previously operated under the name Syneron-Candela before rebranding as Candela in 2019.

Candela develops and manufactures a comprehensive portfolio of medical aesthetic laser, Intense Pulsed Light (IPL), and Radiofrequency (RF) microneedling machines. Their technologies provide solutions for a broad range of aesthetic applications, including permanent hair reduction, wrinkle reduction, tattoo removal, treatment of vascular and pigmented lesions, skin resurfacing, body contouring, women's health treatments, acne, leg veins, and scar treatment. Key product lines include the Gentle Pro™ Series for hair removal, PicoWay® for tattoo and pigment removal, and the Vbeam® Family for vascular lesions. Candela markets and services its products to plastic surgeons, dermatologists, hospitals, and medical spas in nearly 100 countries.

In terms of patent litigation, Candela Medical, Inc. operates as an operating company that actively defends and asserts its intellectual property. The company has one tracked case, where it appears as a plaintiff in an Inter Partes Review (IPR) before the Patent Trial and Appeal Board (PTAB). This indicates a posture of challenging the validity of a competitor's patent rather than being an NPE asserting an acquired portfolio.

The notable tracked case, Candela Corporation et al. v. Nikolai Tankovich, was filed at the PTAB on November 18, 2022. This IPR (IPR2023-00234) targets a patent related to laser tissue therapy, with Candela alleging obviousness based on prior art. Historically, Candela and its predecessors have engaged in patent litigation in district courts, including settlements in patent infringement lawsuits with companies like Lumenis and InMode, demonstrating a consistent strategy of enforcing its intellectual property rights.